Title:
【発明の名称】キノリン及びキノキサリン化合物
Document Type and Number:
Japanese Patent JP2002530387
Kind Code:
A
Abstract:
This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor or p56lck tyrosine kinase activity, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or T cell activation and proliferation.
Inventors:
Spada Alfred Pea
Heway
Myers Michael Earl
Heway
Myers Michael Earl
Application Number:
JP2000583877A
Publication Date:
September 17, 2002
Filing Date:
November 23, 1999
Export Citation:
Assignee:
Aventis Pharmaceuticals, Inc.
International Classes:
A61F2/06; A61K31/47; A61K31/495; A61K31/498; A61K31/50; A61K31/5377; A61M29/00; A61P1/18; A61P9/00; A61P9/10; A61P11/00; A61P13/12; A61P17/06; A61P19/00; A61P19/08; A61P29/00; C07D215/22; A61P35/00; A61P35/02; A61P43/00; C07D215/14; C07D215/20; C07D215/38; C07D241/42; C07D241/44; C07D241/52; C07D241/54; C07D403/04; C07D405/10; C07D405/12; C07D453/06; C07D215/12; C07D413/00; C07D; (IPC1-7): C07D215/22; A61K31/47; A61K31/498; A61P1/18; A61P9/00; A61P9/10; A61P11/00; A61P13/12; A61P17/06; A61P19/00; A61P29/00; A61P35/00; A61P35/02; A61P43/00; C07D215/38; C07D241/44
Domestic Patent References:
| JPH08224297A | 1996-09-03 | |||
| JPH0956807A | 1997-03-04 | |||
| JPH06507643A | 1994-09-01 | |||
| JPH05502179A | 1993-04-22 | |||
| JP2002530388A | 2002-09-17 |
Foreign References:
| WO1998036784A1 | 1998-08-27 |
Other References:
JPN6010041020, Ｊ． Ｍｅｄ． Ｃｈｅｍ．, 1994, Ｖｏｌ．３７，Ｎｏ．１４, Ｐ．２１２９−２１３７
Attorney, Agent or Firm:
Minoru Nakamura (9 outside)